Recent studies have suggested that preeclampsia-specific DNA methylation patterns in the placenta, e.g., TIMP metallopeptidase inhibitor 3 (TIMP3) and RASSF1A promoters, can be detected in maternal circulation [61, 62]. Here, TIMP3 is linked to preeclampsia.